Vulnerability in Research: Individuals with Limited Financial and/or Social Resources

Council of International Organizations of Medical Sciences (CIOMS) and the World Health Organization (WHO), International Ethical Guidelines for Biomedical Research involving Human Subjects, Geneva, 2002; Kipnis K. , “Vulnerability in Research Subjects: A Bioethical Taxonomy in National Bioethics Advisory Commission,” Ethical and Policy Issues in Research Involving Human Participants, Vol. II, National Bioethics Advisory Committee, Bethesda, 2001.

U.S. Code of Federal Regulations Title 45, Part 46, Protection of Human Subjects of Research.

Levine C. Faden R. Grady C. Hammerschmidt D. Eckenwiler L. Sugarman J. , Consortium to Examine Clinical Research Ethics, “The Limitations of ‘Vulnerability’ as a Protection for Human Research Participants,” American Journal of Bioethics 4, no. 3 (2004): 44–49.

Levine C. , “Research Involving Economically Disadvantaged Participants,” in Emanuel E. Grady C. Crouch R. Lie R. Miller F. Wendler D. , eds., The Oxford Textbook of Clinical Research Ethics (New York: Oxford University Press, 2008): Chapter 40, at 431–436.

DeBruin D. , “Reflections on ‘Vulnerability,’” Bioethics Examiner 5, no. 2 (2001): 1–4.

National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report (Washington, D.C.: Government Printing Office, 1979).

World Medical Association, Inc., Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects , 2000, available at <http://www.wma.net/e/policy/b3.htm> (last visited November 24, 2008).

See CIOMS, supra note 1.

Stone T. H. , “The Invisible Vulnerable: The Economically and Educationally Disadvantaged Subjects of Clinical Research,” Journal of Law Medicine & Ethics 31, no. 1 (2003): 148–153; Noah B. A. , “The Participation of Underrepresented Minorities in Clinical Research,” American Journal of Law and Medicine 29, nos. 2–3 (2003): 221–245.

See National Commission, supra note 6.

Zion D. Gillam L. Loff B. , “The Declaration of Helsinki, CIOMS and the Ethics of Research on Vulnerable Populations,” Nature Medicine 6, no. 6 (2006): 615–617.

Pace C. Miller F. Danis M. , “Enrolling the Uninsured in Clinical Trials: An Ethical Perspective,” Critical Care Medicine 31, no. 3, Supplement (2003): S121–S125.

See Stone , supra note 9.

See Levine , supra note 4, at 433.

Gross C. Filardo G. Mayne S. Krumholz H. , “The Impact of Socioeconomic Status and Race on Trial Participation for Older Women with Breast Cancer,” Cancer 103, no. 3 (2005): 483–491.

Shavers V. L. Lynch C. F. Burmeister L. F. , “Factors that Influence African Americans' Willingness to Participate in Medical Research Studies,” Cancer 91, no. S1 (2001): 233–236; El-Sadr W. Capps L. , “The Challenge of Minority Recruitment in Clinical Trials for AIDS,” JAMA 267, no. 7 (1992): 954–957.

Wendler D. Kington R. Madans J. VanWye G. Christ-Schmidt H. Pratt L. Brawley O. Gross C. Emanuel E. , “Are Racial and Ethnic Minorities Less Willing to Participate in Health Research?” PLOS Medicine 3, no. 2 (2006): 0201–0210.

Adams-Campbell L. Ahaghotu C. Gaskins M. Dawkins F. Smoot D. Polk O. Gooding R. DeWitty R. , “Enrollment of African Americans onto Clinical Treatment Trials: Study Design Barriers,” Journal of Clinical Oncology 22, no. 4 (2004): 730–734.

Cover the Uninsured, “Facts and Research: Fact Cheets,” available at <http://covertheuninsured.org/factsheets> (last visited November 25, 2008).

Denny C. Grady C. , “Clinical Research with Economically Disadvantaged Populations,” Journal of Medical Ethics 33, no. 7 (2007): 382–385.

American College of Physicians, “Racial and Ethnic Disparities in Health Care: A Position Paper of the American College of Physicians,” Annals of Internal Medicine 141, no. 3 (2004): 226–232.

Wu H. W. Nishimi R. M. Page-Lopez C. M. Kizer K. W. , Improving Patient Safety through Informed Consent for Patients with Limited Health Literacy, National Quality Form, Washington, D.C., 2005.

Jefford M. Moore R. , “Improvement of Informed Consent and the Quality of Consent Documents,” The Lancet Oncology 9, no. 5 (2008): 485–493.

Emanuel E. Wendler D. Grady C. , “What Makes Clinical Research Ethical?” JAMA 283, no. 20 (2000): 2701–2711.

Joffe S. Cook E. Cleary P. Clark J. Weeks J. , “Quality of Informed Consent in Cancer Clinical Trials: A Cross-Sectional Survey,” The Lancet 358, no. 9295 (2001):1772–1777.

Grady C. Pace C. Campbell B. Emanuel E. , “The Quality of Informed Consent for Clinical Research: A Comparative Review of Empirical Data from Developing and Developed Countries” (unpublished manuscript).

Flory J. Emanuel E. , “Interventions to Improve Research Participant Understanding in Informed Consent Research,” Journal of the American Medical Association 292, no. 13 (2004): 1593–1601.

List J. , “Histories of Mistrust and Protectionism: Disadvantaged Minority Groups and Human Subject Research Policies,” American Journal of Bioethics 5, no. 1 (2005): 53–55.

Emanuel E. , “Undue Inducement: Nonsense on Stilts?” American Journal of Bioethics 5, no. 5 (2005): 9–13.

See CIOMS, supra note 1.

Seidenfeld J. Horstmann E. Emanuel E. Grady C. , “Participants in Phase 1 Oncology Research: Are They Vulnerable?” Archives of Internal Medicine 168, no. 1 (2008): 16–20.

Leffers J. Martins D. McGrath M. Brown D. G. Mercer J. Sullivan M. C. Viau P. , “Development of a Theoretical Construct for Risk and Vulnerability from Six Empirical Studies,” Research and Theory for Nursing Practice: An International Journal 18, no. 1 (2004): 15–34.

Faden R. Beauchamp T. , “Coercion, Manipulation, and Persuasion,” in A History and Theory of Informed Consent (New York: Oxford University Press, 1986): Chapter 10, at 337–381.

Macklin R. “Bioethics, Vulnerability, and Protection,” Bioethics 17, nos. 5–6 (2003): 472–486.

Kantian maxim as described in Wertheimer A. , Exploitation (Princeton: Princeton University Press, 1996): at 23–24.

Wertheimer A. , “Exploitation in Clinical Research,” in Emanuel E. Grady C. Crouch R. Lie R. Miller F. Wendler D. , eds., The Oxford Textbook of Clinical Research Ethics (New York: Oxford University Press, 2008): At 201–210.

Wertheimer A , Exploitation (Princeton, NJ: Princeton University Press, 1996).

Dickert N. Grady C. , “What's the Price of a Research Subject? Approaches to Payment for Research Participation,” New England Journal of Medicine 341, no. 3 (1999): 198–203.

Grady C. Dickert N. Jawetz T. Gensler G. Emanuel E. , “An Analysis of U.S. Practices of Paying Research Participants,” Contemporary Clinical Trials 26, no. 3 (2005): 365–375.

See Wertheimer , supra note 38.

See Wertheimer , supra note 37.

See American College of Physicians, supra note 21.

See Stone , supra note 9.

See U.S. Code of Federal Regulations, supra note 2.

See Levine , supra note 4, at 435.